Missed endpoint: trial results

5 resultsMissed endpoint
Missed endpoint

Firmonertinib

Phase 3 n=398 Metastatic Non-Small Cell Lung Cancer

ArriVent AVBP

24h stock move −48.74%
Missed endpoint

Envudeucitinib

Phase 2 n=408 SLE

Alumis ALMS

24h stock move −54.05%
Missed endpoint

TNX-103

Phase 3 n=230 Pulmonary Hypertension

Tenax Therapeutics TENX

24h stock move −89.29%
Missed endpoint

ML-004

Phase 2 n=168 Autism Spectrum Disorder

MapLight MPLT

24h stock move +3.37%
Missed endpoint

ALTO-101

Phase 2 n=82 Schizophrenia

Alto Neuroscience ANRO

24h stock move −7.39%